June 3 (Reuters) - Exagen Inc:
* EXAGEN INC. ANNOUNCES CLINICAL TRIAL CONDUCTED AT MAJOR ACADEMIC CENTER IN DISTINGUISHING TYPE 1 AND TYPE 2 LUPUS
* EXAGEN INC - ANNOUNCED CLINICAL TRIAL IN COLLABORATION WITH DUKE UNIVERSITY IN DURHAM, NC Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.